Establishment Labs Executive and Leadership Team

October, 2026

Leadership Overview

Establishment Labs has 5 executives leading key functions including corporate strategy, innovation, financial oversight, technical development, and regulatory compliance.

Focused on advancing women's health through medical technology, Establishment Labs delivers transformative solutions for breast aesthetics and reconstruction while maintaining a commitment to scientific excellence and global market expansion.

Leadership Roles at Establishment Labs

  • Chief Executive Officer - Peter Caldini
  • Founder & Chief Executive Officer - Juan Chacon Quiros
  • Chief Financial Officer - Sandra Harris
  • Chief Technology Officer - Roberto de Mezerville
  • Chief Compliance Officer & General Counsel - Ross Mansbach
  • Peter Caldini - Chief Executive Officer

    Peter Caldini, the Chief Executive Officer at Establishment Labs, directs the overarching corporate strategy and global commercial operations. Overseeing the expansion of Femtech solutions across international markets, the Chief Executive Officer ensures alignment between clinical innovation and commercial scalability. This leadership role involves managing complex stakeholder relationships and driving the adoption of breast health technologies in diverse healthcare environments. By optimizing operational efficiency, Peter Caldini directly impacts the company's ability to deliver high-quality medical devices to patients worldwide. Caldini maintains a focus on sustainable growth, ensuring that the organization remains at the forefront of medical technology. Through rigorous oversight of market penetration strategies, the Chief Executive Officer secures the long-term competitive positioning of the firm within the global medical device sector, ultimately fostering improved health outcomes for women through advanced engineering and scientific research.
    Peter Caldini

    Juan Chacon Quiros - Founder & Chief Executive Officer

    Juan Chacon Quiros, the Founder & Chief Executive Officer at Establishment Labs, architects the long-term vision and foundational scientific mission of the organization. Overseeing the development of breakthrough innovations like Mia Femtech, the Founder & Chief Executive Officer drives the integration of engineering and medical science to redefine breast aesthetics. This leadership role involves cultivating a culture of research and development that supports the company's extensive patent portfolio. By championing disruptive technologies, Juan Chacon Quiros directly influences the trajectory of the medical technology industry. Quiros maintains a focus on the intersection of patient wellness and technological advancement, ensuring that every product meets the highest standards of safety and efficacy. Through strategic guidance of the executive team, the Founder & Chief Executive Officer sustains the company's reputation for excellence, consistently pushing the boundaries of what is possible in reconstructive and aesthetic breast health solutions.
    Juan Chacon Quiros

    Sandra Harris - Chief Financial Officer

    Sandra Harris, the Chief Financial Officer at Establishment Labs, manages the financial health and capital allocation strategies necessary to support global operations. Overseeing fiscal planning, investor relations, and corporate budgeting, the Chief Financial Officer ensures the company maintains the resources required for ongoing research and development. This leadership role involves navigating complex financial landscapes to support the commercialization of medical technologies across international regions. By optimizing capital structure and financial reporting, Sandra Harris directly impacts the company's ability to scale production and reach new markets. Harris maintains a focus on long-term value creation, providing the financial stability needed to sustain the firm's commitment to women's health. Through rigorous analysis of market trends and operational costs, the Chief Financial Officer supports the strategic objectives of the board, ensuring that financial performance aligns with the broader mission of delivering innovative breast health solutions.
    Sandra Harris

    Roberto de Mezerville - Chief Technology Officer

    Roberto de Mezerville, the Chief Technology Officer at Establishment Labs, directs the engineering and scientific research initiatives that define the company's product portfolio. Overseeing the development of advanced medical devices such as the Motiva Flora tissue expander, the Chief Technology Officer ensures that all innovations adhere to strict regulatory and clinical standards. This leadership role involves managing the intellectual property pipeline and collaborating with scientific teams to publish peer-reviewed studies. By driving the technical evolution of breast health solutions, Roberto de Mezerville directly impacts the efficacy and safety of the company's offerings. de Mezerville maintains a focus on integrating cutting-edge materials science into clinical practice, ensuring that the firm remains a leader in medical technology. Through the continuous refinement of manufacturing processes and product design, the Chief Technology Officer supports the company's mission to improve women's health through superior engineering and technological breakthroughs.
    Roberto de Mezerville

    Ross Mansbach - Chief Compliance Officer & General Counsel

    Ross Mansbach, the Chief Compliance Officer & General Counsel at Establishment Labs, directs the legal framework and regulatory adherence strategies essential for global operations. Overseeing corporate governance, risk management, and international regulatory filings, the Chief Compliance Officer & General Counsel ensures that all business activities align with medical device standards and legal requirements. This leadership role involves protecting the company's extensive patent portfolio and navigating the complexities of global healthcare regulations. By mitigating legal risks and ensuring ethical conduct, Ross Mansbach directly impacts the company's ability to operate in diverse international markets. Mansbach maintains a focus on maintaining the integrity of the firm's scientific and commercial operations, providing the legal foundation necessary for sustained growth. Through proactive management of legal affairs, the Chief Compliance Officer & General Counsel supports the executive team in achieving strategic goals while upholding the highest standards of corporate responsibility and patient safety.
    Ross Mansbach

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Establishment Labs Top Executives and Leadership Team

    Who leads Establishment Labs?
    Establishment Labs is led by Peter Caldini (Chief Executive Officer), along with executives such as Juan Chacon Quiros (Founder & Chief Executive Officer) and Sandra Harris (Chief Financial Officer).
    Who is part of Establishment Labs’s executive team?
    The executive team of Establishment Labs includes leaders such as Peter Caldini (Chief Executive Officer), Juan Chacon Quiros (Founder & Chief Executive Officer), Sandra Harris (Chief Financial Officer) and other senior executives.
    How many executives does Establishment Labs have?
    Establishment Labs has 5 executives leading key business areas.
    What roles are included in Establishment Labs’s leadership team?
    The leadership team of Establishment Labs includes roles such as Chief Executive Officer, Founder & Chief Executive Officer, Chief Financial Officer, Chief Technology Officer, Chief Compliance Officer & General Counsel.